Diane Gerst
Net worth: 823 313 $ as of 2026-09-29
Net worth: 823 313 $ as of 2026-09-29
Diane Gillett Gerst is currently an Independent Director at Amphastar Pharmaceuticals, Inc. since 2019 and a Director at Amphastar Nanjing Pharmaceuticals Co., Ltd. Formerly, Ms. Gerst was President of Amphastar Nanjing Pharmaceuticals, Inc. from 2014 to 2018.
Ms. Gerst completed undergraduate education at the University of California, Berkeley.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-31 | 31,899 ( 0.07% ) | 823 313 $ | 2026-09-29 |
| Companies | Position | Start |
|---|---|---|
| AMPHASTAR PHARMACEUTICALS, INC. | Director/Board Member | 2019-05-31 |
Amphastar Nanjing Pharmaceuticals Co., Ltd.
Amphastar Nanjing Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures injectable and inhalation drugs | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Amphastar Nanjing Pharmaceuticals, Inc.
Amphastar Nanjing Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | President | 2018-01-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures proprietary injectable and inhalation products | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amphastar Nanjing Pharmaceuticals Co., Ltd.
Amphastar Nanjing Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures injectable and inhalation drugs | Health Technology |
Amphastar Nanjing Pharmaceuticals, Inc.
Amphastar Nanjing Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions